Log In
Print
BCIQ
Print
Print this Print this
 

EVT 770

  Manage Alerts
Collapse Summary General Information
Company Evotec AG
DescriptionBeta cell regeneration factor
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type I and Type II diabetes
Regulatory Designation

Partner

AstraZeneca plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today